Kymera Therapeutics Inc. Common Stock vs Trane Technologies plc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Trane Technologies plc trades at $471.84 (market cap $105.17B). The key difference: Trane Technologies plc is far larger — about 11.9× Kymera Therapeutics Inc. Common Stock's market cap, and Trane Technologies plc pays a 0.88% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.
| KYMR | TT | |
|---|---|---|
Market Cap | $8.87B | $105.17B |
Volume | 779,107 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $127.31 | $503.46 |
52-Week Low | $55.80 | $376.43 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $8.26B | $108.47B |
Dividend Yield | — | 0.88% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →